Fludarabine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical CenterSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 59/ 100
- Competitive Position
- 81/ 100
Competitive context
78 Active assets in the Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM City of Hope Medical Center | Phase 2/3 | BBB |
Cytosin-Arabinosid National Cancer Institute (NCI) | Phase 3 | BBB |
Daunorubicin National Cancer Institute (NCI) | Phase 3 | BBB |
ETOPOSIDE M.D. Anderson Cancer Center | Phase 3 | BB |
Idarubicine Fred Hutchinson Cancer Center | Phase 2/3 | BB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →